Company Filing History:
2 out of 5,089 
1 out of 230 
1 out of 8 Years Active: 2011-2016
Title: The Innovative Contributions of Gilles Audoly
Introduction
Gilles Audoly is a notable inventor based in Marseilles, France. He has made significant contributions to the field of virology, particularly in the study of HIV proteases. With a total of 2 patents, his work has advanced the understanding of antiviral resistance and sensitivity.
Latest Patents
Audoly's latest patents include a yeast-based assay for measuring the functional activity of an HIV-1 protease in response to an antiviral agent. This method involves amplifying sequences coding for a retrovirus protease, recombining DNA fragments with an expression vector, and culturing transformed yeast cells to perform sensitivity or resistance tests. Another patent focuses on determining HIV-2 protease sensitivity or resistance to antivirals using an inducible yeast expression system. This method includes causing cell lysis of yeast by expressing the retrovirus protease, which aids in understanding the effectiveness of therapeutic treatments.
Career Highlights
Throughout his career, Gilles Audoly has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université d'Aix-Marseille. His research has been pivotal in developing methods that enhance the understanding of HIV treatment options.
Collaborations
Audoly has collaborated with notable colleagues, including Pablo Gluschankof and Didier Raoult. These partnerships have contributed to the advancement of research in virology and the development of innovative solutions to combat viral infections.
Conclusion
Gilles Audoly's contributions to the field of virology through his patents and collaborations highlight his commitment to advancing medical science. His innovative methods for studying HIV proteases are crucial in the ongoing fight against viral diseases.